An All-Encompassing Fight Against Cancer
As New Jersey’s only National Cancer Institute-designated Comprehensive Cancer Center, Rutgers Cancer Institute of New Jersey, together
Source: njbmagazine.com
Page 33 - Hematologic Malignancies News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Hematologic Malignancies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Hematologic Malignancies Today - Breaking & Trending Today
Incyte Announces Data from Two LIMBER Studies Evaluating Combination Treatments in Patients with Myelofibrosis (MF) Presented at ASH 2022
- Phase 2 data demonstrate that the addition of parsaclisib to ruxolitinib (Jakafi®) resulted in spleen volume reduction and improvement in symptom burden in patients with myelofibrosis (MF) - Initial results of a Phase 1/2 study evaluating the safety and tolerability of INCB00928, an ALK2 inhibitor, show INCB00928 improves anemia in patients with MF both as monotherapy and in combination with ruxolitinib - These studies are part of our LIMBER program evaluating ruxolitinib combinations and potential new targets for appropriate patients with myeloproliferative neoplasms (MPNs)
Source: marketscreener.com
Servier Presents Patient Follow Up Data from the Phase 3 AGILE Study at ASH 2022
/PRNewswire/ -- Servier, a leader in oncology committed to bringing the promise of tomorrow to the patients we serve, today presented new data at the 64th...
Source: prnewswire.com
Bionano Genomics Announces American Society of Hematology
A scientific workshop will feature Dr. Rashmi Kanagal-Shamanna from the University of Texas MD Anderson Cancer Center delivering a presentation on the use...
Source: globenewswire.com
Stem Cell Therapy Market is expected to generate a revenue of USD 296.14 Million by 2028, Globally, at 10.97% CAGR: Verified Market Research®
/PRNewswire/ -- Verified Market Research recently published a report, "Stem Cell Therapy Market" By Cell Source (Adipose Tissue-Derived Mesenchymal Stem Cells,...
Source: prnewswire.com